Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells

Hung Q. Doan, Kanika Bowen-Jallow, Lindsey A. Jackson, B. Mark Evers

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Toll-like receptors (TLRs) are involved in innate immunity. Overexpression of TLRs has been implicated in various types of cancer including colorectal cancer (CRC). The phosphatidylinositol-3'-kinase (PI3K)/Akt signaling pathway is involved in CRC growth and progression. In this study, we determined whether TLR4 signaling and PI3K/Akt pathway activation occur in CRCs. Materials and Methods: Human CRCs and adjacent mucosa were evaluated for TLR4 expression. CRC cell lines were treated with lipopolysaccharide (LPS), endogenous TLR4 ligand, to assess Akt phosphorylation. Results: Human CRCs overexpressed TLR4 compared to matched normal mucosa. Additionally, TLR4 was expressed in CRC cells and LPS treatment increased Akt phosphorylation of TLR4-positive CRCs in a time-dependent manner. Conclusion: Our results identify TLR4 expression in human CRCs and activation of PI3K with LPS treatment. These findings suggest possible treatment strategies targeting TLR4 in CRC.

Original languageEnglish (US)
Pages (from-to)2473-2478
Number of pages6
JournalAnticancer Research
Volume29
Issue number7
StatePublished - Jul 2009

Fingerprint

Toll-Like Receptor 4
Colonic Neoplasms
Phosphatidylinositol 3-Kinase
Colorectal Neoplasms
Phosphorylation
Lipopolysaccharides
Toll-Like Receptors
Mucous Membrane
Innate Immunity
Ligands
Cell Line
Growth
Neoplasms

Keywords

  • Akt
  • Colon cancer
  • Inflammation
  • Toll-like receptors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. / Doan, Hung Q.; Bowen-Jallow, Kanika; Jackson, Lindsey A.; Evers, B. Mark.

In: Anticancer Research, Vol. 29, No. 7, 07.2009, p. 2473-2478.

Research output: Contribution to journalArticle

Doan, Hung Q. ; Bowen-Jallow, Kanika ; Jackson, Lindsey A. ; Evers, B. Mark. / Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. In: Anticancer Research. 2009 ; Vol. 29, No. 7. pp. 2473-2478.
@article{b21467f38f834a7698946f8794d1e726,
title = "Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells",
abstract = "Background: Toll-like receptors (TLRs) are involved in innate immunity. Overexpression of TLRs has been implicated in various types of cancer including colorectal cancer (CRC). The phosphatidylinositol-3'-kinase (PI3K)/Akt signaling pathway is involved in CRC growth and progression. In this study, we determined whether TLR4 signaling and PI3K/Akt pathway activation occur in CRCs. Materials and Methods: Human CRCs and adjacent mucosa were evaluated for TLR4 expression. CRC cell lines were treated with lipopolysaccharide (LPS), endogenous TLR4 ligand, to assess Akt phosphorylation. Results: Human CRCs overexpressed TLR4 compared to matched normal mucosa. Additionally, TLR4 was expressed in CRC cells and LPS treatment increased Akt phosphorylation of TLR4-positive CRCs in a time-dependent manner. Conclusion: Our results identify TLR4 expression in human CRCs and activation of PI3K with LPS treatment. These findings suggest possible treatment strategies targeting TLR4 in CRC.",
keywords = "Akt, Colon cancer, Inflammation, Toll-like receptors",
author = "Doan, {Hung Q.} and Kanika Bowen-Jallow and Jackson, {Lindsey A.} and Evers, {B. Mark}",
year = "2009",
month = "7",
language = "English (US)",
volume = "29",
pages = "2473--2478",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells

AU - Doan, Hung Q.

AU - Bowen-Jallow, Kanika

AU - Jackson, Lindsey A.

AU - Evers, B. Mark

PY - 2009/7

Y1 - 2009/7

N2 - Background: Toll-like receptors (TLRs) are involved in innate immunity. Overexpression of TLRs has been implicated in various types of cancer including colorectal cancer (CRC). The phosphatidylinositol-3'-kinase (PI3K)/Akt signaling pathway is involved in CRC growth and progression. In this study, we determined whether TLR4 signaling and PI3K/Akt pathway activation occur in CRCs. Materials and Methods: Human CRCs and adjacent mucosa were evaluated for TLR4 expression. CRC cell lines were treated with lipopolysaccharide (LPS), endogenous TLR4 ligand, to assess Akt phosphorylation. Results: Human CRCs overexpressed TLR4 compared to matched normal mucosa. Additionally, TLR4 was expressed in CRC cells and LPS treatment increased Akt phosphorylation of TLR4-positive CRCs in a time-dependent manner. Conclusion: Our results identify TLR4 expression in human CRCs and activation of PI3K with LPS treatment. These findings suggest possible treatment strategies targeting TLR4 in CRC.

AB - Background: Toll-like receptors (TLRs) are involved in innate immunity. Overexpression of TLRs has been implicated in various types of cancer including colorectal cancer (CRC). The phosphatidylinositol-3'-kinase (PI3K)/Akt signaling pathway is involved in CRC growth and progression. In this study, we determined whether TLR4 signaling and PI3K/Akt pathway activation occur in CRCs. Materials and Methods: Human CRCs and adjacent mucosa were evaluated for TLR4 expression. CRC cell lines were treated with lipopolysaccharide (LPS), endogenous TLR4 ligand, to assess Akt phosphorylation. Results: Human CRCs overexpressed TLR4 compared to matched normal mucosa. Additionally, TLR4 was expressed in CRC cells and LPS treatment increased Akt phosphorylation of TLR4-positive CRCs in a time-dependent manner. Conclusion: Our results identify TLR4 expression in human CRCs and activation of PI3K with LPS treatment. These findings suggest possible treatment strategies targeting TLR4 in CRC.

KW - Akt

KW - Colon cancer

KW - Inflammation

KW - Toll-like receptors

UR - http://www.scopus.com/inward/record.url?scp=69249176159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249176159&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 2473

EP - 2478

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -